CETIRIZINE HYDROCHLORIDE ALLERGY

Post-LOE

cetirizine hcl

Jubilant Therapeutics

ANDAORALCAPSULE

Approved

Jul 2017

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

3/8 — Basic

CETIRIZINE HYDROCHLORIDE ALLERGY (cetirizine hcl) by Jubilant Therapeutics. Approved for these symptoms due to hay fever, other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose and 1 more indications. First approved in 2017.

Drug data last refreshed 1w ago

Mechanism of Action

Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.

Indications (4)

these symptoms due to hay fever other upper respiratory allergies: runny nose sneezing itchy

Worked on CETIRIZINE HYDROCHLORIDE ALLERGY at Jubilant Therapeutics? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Clinical Trials (2)

NCT01651871Phase 2Completed

Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis

Started Jul 2012

779 enrolled

Seasonal Allergic Rhinitis

NCT02932774Phase 4Completed

Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)

Started Mar 2001

683 enrolled

Allergic RhinitisHay FeverSAR+1 more